Helius Medical Technologies Inc (HSDT)
3.590
-0.40
(-10.03%)
USD |
NASDAQ |
May 01, 16:00
3.71
+0.12
(+3.35%)
After-Hours: 20:00
Helius Medical Technologies Enterprise Value: -1.642M for April 30, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 30, 2024 | -1.642M |
| April 29, 2024 | -1.553M |
| April 26, 2024 | -1.189M |
| April 25, 2024 | -1.242M |
| April 24, 2024 | -0.9097M |
| April 23, 2024 | -0.7632M |
| April 22, 2024 | -0.679M |
| April 19, 2024 | -0.6168M |
| April 18, 2024 | -0.6479M |
| April 17, 2024 | -0.5858M |
| April 16, 2024 | -0.4616M |
| April 15, 2024 | -0.0179M |
| April 12, 2024 | 0.2926M |
| April 11, 2024 | 0.1418M |
| April 10, 2024 | 0.0265M |
| April 09, 2024 | 0.1241M |
| April 08, 2024 | 0.2394M |
| April 05, 2024 | 0.2571M |
| April 04, 2024 | 0.2749M |
| April 03, 2024 | 0.5677M |
| April 02, 2024 | -0.1599M |
| April 01, 2024 | -0.1953M |
| March 28, 2024 | -0.009M |
| March 27, 2024 | -0.2131M |
| March 26, 2024 | -0.2309M |
| Date | Value |
|---|---|
| March 25, 2024 | -0.1333M |
| March 22, 2024 | -0.0432M |
| March 21, 2024 | 0.0176M |
| March 20, 2024 | -0.1421M |
| March 19, 2024 | -0.151M |
| March 18, 2024 | -0.0268M |
| March 15, 2024 | -0.1155M |
| March 14, 2024 | -0.3018M |
| March 13, 2024 | -0.009M |
| March 12, 2024 | 0.0753M |
| March 11, 2024 | 0.2128M |
| March 08, 2024 | 0.0708M |
| March 07, 2024 | 0.1418M |
| March 06, 2024 | -0.0978M |
| March 05, 2024 | -0.151M |
| March 04, 2024 | -0.0357M |
| March 01, 2024 | -1.136M |
| February 29, 2024 | -1.139M |
| February 28, 2024 | -1.263M |
| February 27, 2024 | -0.2962M |
| February 26, 2024 | -0.1899M |
| February 23, 2024 | -0.0923M |
| February 22, 2024 | -0.0391M |
| February 21, 2024 | -0.0746M |
| February 20, 2024 | -0.0125M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-10.59M
Minimum
Dec 27 2022
59.04M
Maximum
Jun 05 2019
12.25M
Average
11.63M
Median
Enterprise Value Benchmarks
| ARCA biopharma Inc | 14.73M |
| Cerus Corp | 315.67M |
| NeuroOne Medical Technologies Corp | 26.62M |
| Perspective Therapeutics Inc | 978.51M |
| Electromed Inc | 139.21M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.045M |
| Revenue (Quarterly) | 0.134M |
| Total Expenses (Quarterly) | 2.38M |
| EPS Diluted (Quarterly) | -0.96 |
| Gross Profit Margin (Quarterly) | 32.84% |
| Profit Margin (Quarterly) | -779.9% |
| Earnings Yield | -376.0% |
| Normalized Earnings Yield | -517.69 |